EducationEducation

 

AVHTM will be working hard to bring educational materials to the veterinary community. Keep checking back for updates and new resources that are available to the public.

 

AVHTM SIG at the ACVIM Forum
 

ACVIM Presentations (registration required)

PubMed Articles for Hematology and Transfusion Medicine
 

Transfusion Guidelines



IVECCS Presentations (registration required)


ACVIM

ACVIM Presentations
 

Diagnosis and Management of Venous Thromboemboli: Veterinary Perspective

On Demand CE: 1
Primary Presenter(s)

Marilyn E. Dunn, DMV, MVSc, DACVIM (SAIM)
Professor, University of Montreal
St-Hyacinthe, Quebec, Canada

Thromboembolic disease is often on our differential list however it is difficult to diagnose in clinical patients. Once it is diagnosed, there is much controversy on how it should be managed. Do venous thromboemboli need to be treated? If so, when? how? Does it depend on the location? What follow-up should be done and how can response to therapy be assessed? Is life long therapy required? If not how can therapy be discontinued? What are the benefits of medical therapy. What interventional procedures are available for treatment of venous thromboemboli in dogs and cats. All of these topics will be covered during the talk and the speaker will present a critical review of the literature along with clinical cases.

Learning Objectives:

  • Determine the most useful tests in the diagnosis of venous thromboemboli.
  • Determine when treatment is necessary.
  • Choose whether the patient would most benefit from targeted medical therapy, interventional therapy or both.  Return to top
     

Hunting for the Cause of a Novel Pancytopenia in Cats in the United Kingdom

On Demand CE: 1
Primary Presenter(s)

Karen R. Humm, MA, VetMB, MSc, CertVA, DACVECC, DECVECC, FHEA, MRCVS
Associate Professor in Transfusion Medicine and Emergency and Critical Care
The Royal Veterinary College, North Mymms, England, United Kingdom

Co-Presenter(s)

Barbara Glanemann, DECVIM-CA, PGDiplVetEd, Dr. vet. med., FHEA, MRCVS
Senior Lecturer
Royal Veterinary College, University of London, North Mymms, England, United Kingdom

This lecture will discuss the investigation into the 2021 outbreak of pancytopenia in the UK, describing how the investigation proceeded and the findings.

Learning Objectives:

  • Understanding of how a novel disease outbreak could be approached
  • Understanding of the toxicological effects of mycotoxins in cats  Return to top
     

Venous Thromboembolism: Diagnosis and Treatment of Humans

Friday, June 24, 2022 1:30 PM – 2:30 PM CT Location: ACC Ballroom G CE: 1
Capturing for On Demand

Primary Presenter(s)

Stephan Moll, MD
Professor of Medicine
University of North Carolina School of Medicine, Chapel Hill NC USA

I will discuss standard diagnostic workup of a patient with suspected DVT or PE, explaining the diagnostic pathways using a clinical pretest probability assessment, D-dimer testing, and radiologic imaging studies (venous Doppler ultrasound, lung DT scan, lung ventilation/perfusion scan). I will discuss the pros and cons of the different anticoagulants (DOAC, LMWH, warfarin) when treating a patient with DVT or PE, with particular reference to choice of drug and dosing regimen in patients with renal impairment, severe obesity, liver disease, and antiphospholipid syndrome). I will provide a framework – the ‘DVT recurrence triangle’ - how to think about how long to treat a patient with DVT or PE with anticoagulation. I will discussion which patient to consider thrombophilia testing and how results are used for clinical decision making on length of anticoagulation. Finally, I will provide a handout of my “22 Teaching Points: How to Approach the Human Patient with Venous Thromboembolism”.

Learning Objectives:

  • Recognize the pitfalls of D-dimer use and radiologic imaging studies (venous Doppler ultrasound, lung DT scan, lung ventilation/perfusion scan) when evaluating a patient for venous thromboembolism.
  • Weigh the pros and cons of the different anticoagulants (DOAC, LMWH, warfarin) when choosing an anticoagulant to treat a patient with DVT or PE, particularly the more unusual patient (severely obese, renal impairment, antiphospholipid syndrome).
  • Make decisions how long to treat a patient who has had a venous thromboembolic event with anticoagulants., and what dosing regimen to use.  Return to top
     

Discovery of a Novel Virus Causing Severe Fever and Thrombocytopenia in Cats in Japan

Friday, June 24, 2022 2:45 PM – 3:45 PM CT Location: ACC Ballroom G CE: 1
Capturing for On Demand

Primary Presenter(s)

Claire R. Sharp, BVMS, MS, DACVECC
Associate Professor
Murdoch University, Kardinya, WA AUS

Severe fever with thrombocytopenia syndrome” (SFTS) virus (Dabie bandavirus) emerged in China in 2009, and several epidemics have occurred since that time in Asia. SFTS virus if of interest in veterinary hematology since it has been reported to cause severe thrombocytopenia in cats, and was a differential diagnosis for a recent outbreak of symptomatic thrombocytopenia in cats in the UK. Although not yet identified outside of Asia this virus is important for veterinarians to be aware of given its zoonotic nature, increasing incidence, and the worldwide spread of the tick vector. This lecture will review what we know about this emerging virus, and the disease reported in cats to date.

Learning Objectives:

  • Understand the basic viral pathogenesis of severe fever with thrombocytopenia syndrome virus (SFTSV), including mechanisms of transmission and zoonotic risk
  • Recall the clinical syndrome of SFTSV in cats and potential treatment approaches  Return to top


IVECCS Presentations
 

Crossmatching: Ins, Outs and Controversies

Friday, September 9, 2022 • 8:00 AM - 9:00 AM Central Time (US & Canada) • Hemisfair Ballroom C2
Sarah Musulin, DVM, DACVECC

Maximizing safety and efficacy is paramount when transfusing a patient. This lecture will provide information on when and how to perform pre-transfusion compatibility testing. A brief discussion of canine and feline blood types and blood typing will be followed by indications for crossmatching. The remainder of the lecture will incorporate available literature and provide an understanding about crossmatching methods.  Return to top
 

Approach to the Anemic Cat

Friday, September 9, 2022 • 9:30 AM - 10:30 AM Central Time (US & Canada) • Hemisfair Ballroom C2
Rebecca Walton, DVM, DACVECC

Anemia is a commonly encountered presentation to the emergency clinician or general practitioner and historical findings and clinical signs are often vague and non-specific in cats. Additionally, anemia may develop during hospitalization of the feline patient. Anemia in cats may be due to a multitude of various etiologies including: hemorrhage, hemolysis, decreased production or iatrogenic secondary to repeated sampling. Feline patients presenting with anemia have variable prognoses depending on the underlying etiology and specific therapeutic options.  Return to top
 

Anti-Platelet Therapy: What is Safe and Effective?

Friday, September 9, 2022 • 11:00 AM - 12:00 PM Central Time (US & Canada) • Hemisfair Ballroom C2
John Thomason, DVM, MS, DACVIM

Anti-platelet therapy is commonly used in patients at risk for thromboembolic complications. The best use of these medications is unknown, and inappropriate therapy could be a risk factor for thromboembolism. Based on our ongoing research, this session will review commonly used medications and discuss the newest advances in anti-platelet therapy.  Return to top
 

War Dogs: Case Reports on Our 4-legged Heroes

Friday, September 9, 2022 • 1:30 PM - 2:30 PM Central Time (US & Canada) • 207
Thomas Edwards, DVM, MS, DACVECC

Military Working Dogs (MWDs) serve a critical role in the War on Terror – detecting explosives meant to destroy coalition forces and neutralizing enemy combatants. However, due to the nature of the work these MWDs perform, they are exposed to the same dangers as their human counterparts. Using information gathered from the recently published, large study on MWDs injured in the line of duty, Lieutenant Colonel (retired) Tom Edwards will walk the audience through some examples of MWD traumas sustained on the battlefield and examine the care that handlers, medics, human health care providers and veterinary personnel rendered to these extraordinary animals.  Case reports from MWDs who were injured by Improvised Explosive Devices and high velocity gunshot wounds will be the focus of the lecture. Each case will take participants from the point of injury where immediate care was provided by combat medics and handlers, to both human and veterinary deployed hospitals and through evacuation from theater for definitive care. Participants will gain a better understanding of the treatment these dogs receive and the efforts that the US Department of Defense go through to care for these amazing dogs.   Return to top
 

Plasma and Albumin Transfusions

Friday, September 9, 2022 • 3:00 PM - 4:00 PM Central Time (US & Canada) • 207
Erin Mays, DVM, DACVECC

Learn the ins and outs of plasma and albumin transfusion in this practical session exploring the pros, cons and controversies associated with administration of these blood products in small animals, particularly in the emergency and critical care setting.  Return to top
 

The Future of Transfusion Medicine

Friday, September 9, 2022 • 4:15 PM - 5:15 PM Central Time (US & Canada) • 207
Erin Mays, DVM, DACVECC

Join this lecture to hear about the cutting edge of transfusion medicine- where the old is new and the future is now!  We will cover novel concepts in storage, stability, and synthesis of blood products and how this is impacting veterinary transfusion practices.  Return to top
 

Lessons Learned from the Battlefield: Hemorrhage Control

Saturday, September 10, 2022 • 8:00 AM - 9:00 AM Central Time (US & Canada) • Hemisfair Ballroom C2
Colonel Andrew Cap

Col Cap is a physician-scientist and officer in the U.S. Army.  His clinical work is in the field of critical care hematology, and his research group focuses on developing products to improve the care of patients suffering massive hemorrhage due to trauma.  Lt. Col. Andrew Cap is the Chief of Coagulation and Blood Research at US Army Institute of Surgical ResearchReturn to top
 

Lessons Learned from the Battlefield: Transfusion Advances

Saturday, September 10, 2022 • 9:30 AM - 10:30 AM Central Time (US & Canada) • Hemisfair Ballroom C2
Colonel Andrew Cap

Col Cap is a physician-scientist and officer in the U.S. Army.  His clinical work is in the field of critical care hematology, and his research group focuses on developing products to improve the care of patients suffering massive hemorrhage due to trauma.  Lt. Col. Andrew Cap is the Chief of Coagulation and Blood Research at US Army Institute of Surgical ResearchReturn to top
 

Lessons Learned from the Battlefield: Application to Veterinary Medicine

Saturday, September 10, 2022 • 11:00 AM - 12:00 PM Central Time (US & Canada) • Hemisfair Ballroom C2
Thomas Edwards, DVM, MS, DACVECC

Since September 11, 2001, the field of traumatology has advanced substantially due to the need to treat severely injured servicemen in the Iraq and Afghanistan wars. The purpose of this presentation is to review the most significant advancements that have been made from knowledge gained in treating wounded servicemen on the battlefield, review veterinary experiences in these areas and examine how these advancements can potentially be adapted to veterinary medicine. Advances to be discussed include stopping the bleed (use of extremity, junctional and endovascular tourniquets), damage control resuscitation & surgery, and advances in hemostatic dressings. Transfusion advances to include limiting crystalloid and synthetic colloids in trauma, 1:1:1 component transfusions, the use of chilled whole blood for resuscitation in trauma, and early use of antifibrinolytics for trauma. In addition, the presentation will cover other areas that have led to decreased mortality and morbidity on the battlefield to include the development and application of clinical practice guidelines.  Return to top

 

Contact Us

AVHTM
PO Box 1234
Sahuarita AZ 85629-1004 USA
info@avhtm.org

Connect With Us

2022 Association of Veterinary Hematology & Transfusion Medicine Inc All Rights Reserved.